1-3 of 3
Roy Lobb
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterization of Aleta-001, a CAR T Engager Designed to Optimize Responses and Prevent Relapses from CAR-19 Therapy

Paul Rennert, Lihe Su, Lan Wu, Roy Lobb, Christine Ambrose
Journal: Blood
Blood (2021) 138 (Supplement 1): 1713.
https://doi.org/10.1182/blood-2021-153295
Published: 2021
Journal Articles

A Novel CD19-Anti-CD20 Bridging Protein Prevents and Reverses CD19-Negative Relapse from CAR19 T Cell Treatment In Vivo

Paul Rennert, PhD, Lihe Su, PhD, Fay Dufort, PhD, Alyssa Birt, MS, Tom Sanford, Lan Wu, PhD, Christine Ambrose, PhD, Roy Lobb, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 252.
https://doi.org/10.1182/blood-2019-130654
Published: 2019
Journal Articles

CAR19 T Cells Redirected to Novel Antigens Mediate Robust Cytotoxicity Against Diverse Malignancies

Paul Rennert, PhD, Christine Ambrose, PhD, Lihe Su, PhD, Fay Dufort, PhD, Lan Wu, PhD, Andreas Hombach, PhD, Hinrich Abken, PhD, Roy Lobb, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4457.
https://doi.org/10.1182/blood.V130.Suppl_1.4457.4457
Published: 2017